SCHEMBL9130456

SCHEMBL9130456

Cc1cnc(S)c(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21099399 0.79 — —
SCHEMBL20670953 0.75 — —
SCHEMBL25999369 0.75 — —
SCHEMBL21657037 0.75 — —
SCHEMBL15944409 0.75 — —
SCHEMBL11823349 0.75 — —
SCHEMBL3651726 0.75 NOS3 (0.39) —
SCHEMBL29382337 0.72 — —
SCHEMBL7487 0.72 — —
SCHEMBL9784696 0.72 NOS3 (0.56) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970345-B1 18F-LABELED PSMA-TARGETED PET IMAGING AGENTS CANCER TARGETED TECH LLC (US) 2019-06-19 — — EP disclosed
US-5399488-A Kidneys NITTO BOSEKI CO., LTD. (JP) 1995-03-21 — — US disclosed
Send feedback